Vir Biotechnology, Inc. VIR Unrecognized Tax Benefits
Unrecognized Tax Benefits at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefits.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s unrecognized tax benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s unrecognized tax benefits?
- Vir Biotechnology, Inc. (VIR) reported unrecognized tax benefits of $17.9M in Q1 2026.
- How has Vir Biotechnology, Inc.'s unrecognized tax benefits changed year-over-year?
- Vir Biotechnology, Inc.'s unrecognized tax benefits decreased by 3.2% year-over-year, from $18.5M to $17.9M.
- What is the long-term trend for Vir Biotechnology, Inc.'s unrecognized tax benefits?
- Over 3 years (2022 to 2025), Vir Biotechnology, Inc.'s unrecognized tax benefits has grown at a 17.7% compound annual growth rate (CAGR), from $10.6M to $17.3M.
- What does unrecognized tax benefits mean?
- This represents the amount of tax benefits from uncertain tax positions that have not been recognized in the financial statements because they do not meet the 'more-likely-than-not' threshold. It reflects the company's exposure to potential tax audits and disputes with tax authorities. This is a key indicator of tax-related legal and financial risk.